Viewing StudyNCT04485676



Ignite Creation Date: 2024-05-06 @ 2:58 PM
Last Modification Date: 2024-10-26 @ 1:41 PM
Study NCT ID: NCT04485676
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2020-06-16

Brief Title: Dalbavancin in Real Clinical Practice in Spain
Sponsor: Angelini Farmacéutica
Organization: Angelini Farmacéutica

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-07-15
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-31
Primary Completion Date Type: ACTUAL
Completion Date: 2021-02-21
Completion Date Type: ACTUAL
First Submit Date: 2020-06-16
First Submit QC Date: July 21 2020
Study First Post Date: 2020-07-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-21
Last Update Post Date: 2022-07-22
Last Update Post Date Type: ACTUAL